Our studies, involving loss and gain of function studies in mice, also provided further insights into the gene regulatory interactions among Foxa1, Foxa2 and Shh in ventral midbrain progenitors that contribute to midbrain patterning. Altogether, these data indicate that Foxa1 and Foxa2 contribute to the specification of ventral midbrain progenitor identity by regulating Shh signalling in a positive and negative manner.
Introduction
The generation of distinct cell types in the vertebrate central nervous system is regulated in a concentration dependent manner by the morphogen Sonic hedgehog (Shh). Shh, secreted by the notochord and floor plate, controls the specification of ventral cell types. Five distinct classes of ventral neurons can be generated in neural plate explants in response to progressive 2-to 3-fold changes in extracellular Shh concentration (Ericson et al., 1996 (Ericson et al., , 1997 . The major transcription factors that mediate Shh signals in the mouse are the Gli zinc-finger proteins, Gli1, Gli2 and Gli3, that directly regulates Shh target genes by binding to a conserved consensus DNA motif. Gli1 is a transcriptional target of the Shh pathway activator (Bai et al., 2002) , while Gli2 transcription is not dependent on Shh (Bai and Joyner, 2001) . However, the 0925-4773/$ -see front matter Ó 2010 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2010.11.002 conversion of Gli2 proteins into a transcriptional activator requires Shh signalling. In the absence of Shh signalling, Gli2 proteins appear to be largely degraded via bTrCP-mediated ubiquination and proteolysis (Pan et al., 2006) . Gli2 is mostly regarded as a transcriptional activator although recent genetic analyses of Gli2 and Gli3 double mutants have suggested that Gli2 also has a weak repressing actively (Buttitta et al., 2003; McDermott et al., 2005) . In contrast, Gli3 mainly acts as a transcriptional repressor because the majority of full length Gli3 protein is proteolytically processed (Litingtung and Chiang, 2000; Pan et al., 2006) . Recent studies demonstrate that the incremental two-to threefold changes in Shh concentration, which determine alternative neuronal subtypes, are mimicked by similar small changes in the level of Gli activity, indicating that a gradient of Gli activity represents the intracellular correlate of graded Shh signalling (Stamataki et al., 2005) . In addition, experiments using chick neural plate explants demonstrate that neural cells integrate the level of signalling over time, consistent with the idea that signal duration, in addition to signal strength, is an important parameter controlling dorsal-ventral patterning in the central nervous system (Stamataki et al., 2005; Dessaud et al., 2007 Dessaud et al., , 2010 . Downstream of Glis, a set of homeodomain transcription factors expressed by neural progenitors act to specify distinct progenitor identities that give rise to different neuronal subtypes (Dessaud et al., 2007) . Nkx2.2 homeodomain protein belongs to the set of factors whose expression requires Shh signalling for their expression. The pattern of generation of certain neuronal subtypes is perturbed in mice carrying a mutation in the Nkx2.2 gene (Briscoe et al., 1999) , supporting a role for Nkx2.2 in regulating neuronal identity. Nkx2.2 is expressed in the midbrain in a pattern distinct from its expression in the hindbrain and spinal cord (Puelles et al., 2004) . Recent analysis of Otx2 conditional mutant embryos have shown that ectopic Nkx2.2 into ventral midbrain progenitors resulted in the generation of hindbrain serotonergic neurons at the expense of midbrain neuronal subtypes including dopaminergic neurons (Prakash et al., 2006; Vernay et al., 2005) . Hence the precise regulation of Nkx2.2 expression is critical for the generation of neuronal subtypes in the ventral midbrain.
The winged helix transcription factor Foxa2 is also induced by Shh and is expressed broadly in ventral midbrain progenitors overlapping with the Nkx2.2 domain (Ferri et al., 2007) . Foxa2 has previously been shown to regulate notochord and floor plate development, likely by regulating Shh expression (Ang and Rossant, 1994; Weinstein et al., 1994) . However, the wider domain of Foxa2 in midbrain basal plate progenitors suggested that Foxa2 could also have additional and later roles in regulating progenitor identity.
In this paper, we have studied genetic interactions among Foxa1, Foxa2 and Shh that are involved in specifying identity of midbrain progenitors using single and double mutants of Foxa1 and/or Foxa2 in mice. Foxa2 is deleted specifically in all midbrain progenitors except medial floor plate cells in Wnt1cre; Foxa2flox/flox (referred to as Foxa2-Wnt1 cko) embryos. Interestingly, expression of Foxa1 and Shh is transiently lost in the ventral midbrain of Foxa2-Wnt1 cko mutant embryos between E8.5 and E10.5. Foxa1 plays a role in the recovery of Shh expression from E10.5 onwards, since there is a permanent loss of Shh expression in basal plate progenitors of Foxa2-Wnt1 cko embryos in a Foxa1 À/À mutant background. In contrast, pharmacological inhibition of Shh signalling at E9.5 did not affect the recovery of Foxa1 expression in Foxa2-Wnt1 cko mutant embryos. Our results also show that Foxa1 and Foxa2 regulate the ventral limit of Gli1, Gli2, Ptch1 and Nkx2.2 expression. Chromatin immunoprecitipation (ChIP) experiments demonstrates that Foxa2 directly binds Gli2 genomic sequences which suggest a direct role for Foxa genes in inhibiting Gli2 expression and consequently cell fates by regulating intracellular Shh signalling. Altogether, these results identify a novel and redundant role for Foxa1 and Foxa2 in specifying midbrain progenitor identity via a novel mechanism, i.e., arresting the ability of cells to respond to Shh signalling by Gli2 transcriptional repression. These data also establish that Foxa1 and Foxa2 are also required in midbrain progenitors for the spreading of Shh expression from the floor plate to basal progenitors.
Results

Genetic interactions among Foxa1, Foxa2 and Shh in the ventral midbrain
Foxa1, Foxa2 and Shh are expressed in a similar pattern in the floor plate of the midbrain of mouse embryos at E8.5 ( Fig. 1Aa and Ab). At E9.5 and E10.5, the expression of all three proteins in the midbrain overlap to a large extent (Fig. 1Ac Af), except for a group of cells near the alar/basal boundary (arrow in Fig. 1Ad and Af) that expresses only Foxa2. Shh expression in the floor plate subsequently decreases, while the expression of Foxa1 and Foxa2 remains unchanged at E11.5 and E12.5 ( Fig. 1Ag-Aj) . In summary, expression of Foxa2, Foxa1 and Shh expression overlap to a large extent suggesting that there may be cross-regulatory interactions among these genes during these embryonic stages.
Since Foxa2 null mutant embryos die at E9.5 due to gastrulation defects (Ang and Rossant, 1994) , we used the Cre-loxP system to specifically inactivate Foxa2 in the midbrain. A Wnt1-Cre transgene was used to inactivate Foxa2 in midbrain progenitors. Analysis of Foxa2 expression by immunohistochemistry demonstrated that Foxa2 is deleted in all midbrain progenitors of Wnt1cre; Foxa2 flox/flox (referred to as Foxa2-Wnt1 cko) embryos from E8.5 to E12.5 (Fig. 1B) , except for medial floor plate cells likely due to the absence of Wnt1 and consequently Cre expression in these cells in Foxa2-Wnt1 cko embryos. Previous studies have shown that Foxa2 is required for expression of Shh in the notochord (Ang and Rossant, 1994) . In contrast, Foxa2 is required for Foxa1 expression in the visceral endoderm based on in vitro differentiation of Foxa2 À/À ES cells (Duncan et al., 1998) , but Foxa2 is not required for Foxa1 expression in early definitive endoderm (Ang and Rossant, 1994) . Consistent with the idea that Foxa2 acts upstream of both Foxa1 and Shh, Foxa1 and Shh expression are detected only in residual Foxa2
+ cells in the midbrain of Foxa2-Wnt1 cko embryos at E8.5 and E9.5 (Fig. 2c, d , g and h) and in the posterior midbrain of Foxa2-Wnt1 cko embryos at E10.5 ( Fig. 2k and l) , while all three genes are similarly expressed in a broader domain in the ventral midbrain of control embryos at these stages (Fig. 2a, b , e, f, i and j). Strikingly, Foxa1 and Shh expression was concomitantly recovered in the anterior midbrain at E10.5 ( Fig. 2m and n) and in the entire midbrain at E12.5 ( Fig. 2q and r) . These results indicate that Foxa2 is required transiently for the expression of Shh and Foxa1 in the ventral midbrain between E8.5 and E10.5, and suggests that Foxa1 may be compensating for Foxa2 in maintaining the expression of Shh at E10.5. In addition, the recovery of Foxa1 and Shh is faster in the anterior midbrain than in the posterior midbrain where recovery of Foxa1 and Shh expression occurs only from E10.5 onwards ( Fig. 2m and n of Foxa2, but it functions redundantly with Foxa2 to induce Shh expression in the ventral midbrain.
In agreement, forced expression of Foxa1 into dorsal midbrain progenitors of E10.5 embryos resulted in activation of Shh expression in some of these progenitors after three days culture ( Fig. 3A and B) . In contrast, Foxa2 was not induced by over-expression of Foxa1 in dorsal midbrain progenitors (Fig. 3A and C) . Forced expression of Foxa2 also resulted in ectopic induction of Shh and Foxa1, indicating that Foxa2 is able to induce the expression of these genes in dorsal midbrain progenitors ( Fig. 3D-F ). As expected, electroporation of control GFP vectors had no effect on Foxa1, Foxa2 and Shh expression ( Fig. 3G-I ). Altogether, these results indicate that while both Foxa1 and Foxa2 are able to induce Shh expression, Foxa2 is able to induce Foxa1 expression but not vice versa in dorsal midbrain progenitors.
Since Shh has been shown to regulate Foxa2 expression through Gli binding sites , we also assessed whether Shh is also required for the expression of Foxa1. We therefore determined whether the recovery of Foxa1 expression in Foxa2-Wnt1 cko embryos is dependent on Shh signalling. To do this, we interfered with Shh signalling by treating E9.5 mouse embryos with cyclopamine, a pharmacological inhibitor of the Shh receptor smoothened and subsequently cultured the embryos for two days. Foxa1 and Foxa2 expression did not change in cyclopamine-treated compared with ethanol-treated Foxa2-Wnt1 cko embryos after culture (Fig. 4A and C) . In contrast, the expression of Nkx2.2 and Nkx6.1, downstream targets of Shh, are severely down regulated in cyclopamine-treated compared to ethanol-treated Foxa2-Wnt1 cko embryos ( Fig. 4B and D) , confirming an interference of Shh signalling in the former embryos. Altogether, these results suggest that the recovery of Foxa1 expression is independent of Shh signalling from E9.5 onwards. In addition, treatment of control embryos with cyclopamine also resulted in reduction of Nkx2.2 and Nkx6.1 expression, but no change in the expression of Foxa1 and Foxa2 indicating that Foxa1 and Foxa2 expression in the midbrain are no longer dependent on Shh signalling after E9.5 ( Fig. 4E and F signalling. In addition, Foxa1 and Foxa2 function redundantly to induce Shh expression in the ventral midbrain. Consistent with a role of Foxa1 and Foxa2 in regulating Shh expression, both Foxa1 and Foxa2 are able to induce Shh expression in dorsal midbrain progenitors in over-expression studies.
2.2.
Foxa1 and Foxa2 regulate the ventral limit of Nkx2.2, Ptch1, Gli1, and Gli2 expression Foxa2 expression in the ventral midbrain overlaps with Nkx2.2 starting at E9.5, but the co-expression pattern of these genes becomes progressively restricted to the alar/basal plate boundary at E12.5 (Fig. 5A, C , E and G). The progressive segregation of Foxa2 and Nkx2.2 expression raises the possibility that Foxa2 may be involved in the progressive dorsal restriction of Nkx2.2 expression. We therefore determined whether Nkx2.2 expression is affected in Foxa2-Wnt1 cko mutant embryos. In wild-type embryos, Nkx2.2 is expressed throughout the ventral midbrain, except the ventral midline at E9.5 (Fig. 5A ). Subsequently this expression becomes progressively restricted to a few rows of cells at and below the alar/basal boundary (Fig. 5C, E and G) . The initiation of Nkx2.2 expression in the midbrain occurs normally (Fig. 5B) , however the reduction of the domain of Nkx2.2 expression in the ventral midbrain does not occur in Foxa2-Wnt1 cko mutant embryos between E9.5 and E12.5 (Fig. 5D , F and H), indicating that Foxa2 is required to restrict the expression of Nkx2.2 to the alar/basal boundary. We have also previously shown that Foxa1 also contributes to the repression of Nkx2.2 in basal progenitors, since the domain of Nkx2.2 expression in basal progenitors is expanded only in Foxa1 À/À ; NestinCre/+; Foxa2-flox/flox double mutant but not in NestinCre/+; Foxa2 flox/flox single mutant embryos at E12.5 (Ferri et al., 2007) . Altogether these results are consistent with data published in our earlier studies (Lin et al., 2009 ) and indicate that Foxa1 and Foxa2 are required for restricting the expression of Nkx2.2 to the alar/ basal plate boundary. Since Nkx2.2 expression is regulated both by the duration and concentration of Shh signalling, we also determined the status and extent of Shh signalling by examining the expression of targets and/or intracellular transducers of Shh signalling, Ptch1, Gli1 and Gli2, in Foxa2-Wnt1 cko mutant embryos. Ptch1 is a twelve pass transmembrane protein that binds Shh and represses the Shh signalling cell autonomously via inhibiting the activity of a seven-pass transmembrane protein called smoothened (reviewed in Rohatgi and Scott, 2007) . Ptch1, Gli1 and Gli2 are initially widely expressed in the midbrain at E8.5 (Hui et al., 1994; Motoyama et al., 2003) . Subsequently, the ventral limit of Ptch1, Gli1 and Gli2 expression becomes progressively restricted to the alar/basal boundary starting at E9.25 and this expression is maintained in the midbrain of wild-type embryos from E10.5 to E12.5 ( Fig. 6A-L ; Supplementary data Fig. S1 ). The ventral limit of Gli2 expression abuts the dorsal limit of expression of Foxa2 at the alar/basal boundary and there is a gap between Shh and Gli2 expression in the ventral midbrain, as revealed by section in situ hybridization with these genes on adjacent sections of wild-type embryos at E12.5 (Supplementary data Fig. S1 ). Expression of all three genes, Ptch1, Gli1 and Gli2, shifted ventrally so that basal progenitors maintained expression of these genes in Foxa2-Wnt1 cko (Fig. 6A', B ', E', F', I' and J'), in contrast to the situation in wild-type embryos (Fig. 6A, B , E, F, I and J) at E9.5 and E10.5. Analogous to the timing of recovery of Foxa1 expression, the normal patterns of expression of all three genes are recovered firstly in the anterior midbrain at E10.5 and then in the whole midbrain from E12.5 onwards. Gli3 expression, on the other hand, appeared normal in wild-type and Foxa2-Wnt1 cko mutant embryos ( Fig. 6M -P, M'-P') from E9.5 to E12.5. Recovery of Ptch1, Gli1 and Gli2 expression did not occur and expression of these genes was also observed in the ventral midline of Foxa2-Wnt1 cko; Foxa1 À/À mutant embryos at E12.5 (Fig. 6D'' , H'' and L''). In addition, Gli3 expression was also observed in scattered cells in the ventral midline of these double mutants (Fig. 6P'' ). Altogether, these results indicate that Foxa1/2 are also required to restrict the ventral limit of expression of Gli1, Gli2 and Ptch1 to the alar/ basal boundary in the ventral midbrain.
Foxa2 binds Gli2 genomic sequences
Gli1 and Ptch1 have been shown to be direct targets of Shh signalling, and previous reports suggest that Gli2 is not a Fig. 4 -Blocking Shh signalling had no effect on the expression of Foxa1 in Foxa2Wnt1 cko embryos. While the expression of Nkx6.1 and Nkx2.2 are severely reduced, Foxa1 expression was similar in cyclopamine-treated and ethanol-treated Foxa2Wnt1 cko embryos. Scale bar = 100 lm.
target of Shh signalling (Bai and Joyner, 2001 ). Consequently, changes in Gli1 and Ptch1 expression may involve alterations in Shh signalling, but which molecule regulates Gli2 expression in the midbrain? Since Gli2 expression is expanded in midbrain progenitors lacking Foxa1 and Foxa2 activity, we therefore investigated whether Foxa2 might directly regulate Gli2 expression. Support for this hypothesis was obtained from a chromatin immunoprecipitation experiment in dopaminergic progenitors using a Foxa2 specific antibody followed by high throughput sequencing (Chip-Seq). The midbrain dopaminergic progenitors (mDA progenitors) were generated by differentiation of NestinLmx1a-transfected mouse ES cells in the presence of Shh and fibroblast growth factor 8 (Andersson et al., 2006) . Data from this Chip-Seq experiment has identified five genomic highly conserved sequences within Gli2 genomic region, termed E1-E5 ( Fig. 7A and B) , that are bound by Foxa2 in these mDA progenitors. Independent Foxa2-ChIP experiments using dissected ventral midbrain cells followed by qPCR analyses using primers specific for E1-E5 regions confirmed that these genomic regions are indeed bound by Foxa2 in the ventral midbrain of mouse embryos at E12.5 (Fig. 7C) . Altogether, these results strongly suggest that Foxa2 directly regulate Gli2 expression in the ventral midbrain.
2.4.
Foxa1 and Foxa2 are required for development of OCM, red nucleus and mDA neurons Since patterning of the ventral midbrain is affected in Foxa2-Wnt1 cko mutant embryos, we next examined whether the development of ventral midbrain neurons are affected in these mutant embryos. The number of TH+ dopaminergic (DA), Brn3a+ red nucleus and Islet1+ oculomotor (OCM) neurons are severely reduced in the midbrain of Foxa2-Wnt1 cko mutant embryos (Fig. 8B, F and J) at E12.5. Remarkably, there is almost complete recovery of OCM and TH+ DA and partial recovery of Brn3a+ neurons in Foxa2-Wnt1 cko mutants by E18.5 (Fig. 8N , V and R, respectively), following the recovery of Foxa1 expression around E11.5. Hence, the delay in the generation of ventral midbrain neurons in Foxa2-Wnt1 cko mutants is likely due to compensation by Foxa1. Consistent with the idea that Foxa1 and Foxa2 can compensate for each other's function in the specification of midbrain progenitors, a much milder phenotype was seen in Foxa1 À/À mutants. In these mutants, a 50% reduction in the number of mDA neurons was seen (Fig. 8C , Ferri et al., 2007 see Fig. 6 ), while Islet1+ OCM and Brn3a+ red nucleus neurons developed normally in these mutants at E12.5 ( Fig. 8G and K) . The reduction in mDA neurons is due to a later role of Foxa1 in postmitotic mDA neurons and not a role of Foxa1 in progenitors (Ferri et al., 2007) . Furthermore, normal numbers of all three types of ventral midbrain neurons were observed in the ventral midbrain of Foxa1 À/À embryos at E18.5 (Fig. 8O , S and W; Ferri et al., 2007) . The recovery of all three subtypes of ventral midbrain neurons does not occur in Foxa1; Foxa2-Wnt1 cko double mutants (Fig. 8P , T and X) indicating that this recovery is dependent on Foxa1. Taken together, these results indicate that Foxa1 and Foxa2 are required and can compensate for each other in the development of OCM, red nucleus and DA neurons in the ventral midbrain.
Discussion
This study has allowed us to demonstrate an early role for Foxa2 in initiating Foxa1 and Shh expression in ventral midbrain progenitors. Subsequently, Foxa1 and Foxa2 function cooperatively to regulate ventral midbrain patterning by down regulating the expression of intracellular transducers Expression of all three genes, Ptch1, Gli1 and Gli2 are shifted ventrally transiently, while there is no change in Gli3 expression in the midbrain of Foxa2-Wnt1 cko single mutant embryos from E9.5 to E12.5. The ventral shift in the expression of all three genes is not rescued in Foxa2-Wnt1 cko; Foxa1 À/À embryos indicating that Foxa1 also has an input into the regulation of these genes. In addition, Gli3 expression was also observed in the ventral midline of the midbrain, where it is normally not expressed in wild-type embryos.
and downstream targets of Shh signalling in ventral midbrain progenitors. In summary, our results indicate that Foxa1/2 act at multiple levels to modulate the response to Shh signalling. We discuss below these distinct roles of Foxa2 and their consequences on midbrain patterning and neuronal subtype generation.
Regulatory interactions among Foxa1, Foxa2 and Shh in the midbrain
Our studies have demonstrated an intricate interaction among Foxa2, Foxa1 and Shh in ventral midbrain progenitors. Foxa2 is required to initiate Foxa1 expression at E8.5, but not vice versa. Foxa1 and Foxa2 induce Shh expression in gain of function experiments suggesting that both Foxa1 and Foxa2 positively regulate Shh expression. In agreement, loss of Foxa1 alone results in no change in Shh expression, due to compensation by Foxa2. In contrast, loss of Foxa2 leads to transient loss of Shh, presumably because Foxa1 expression is also lost in Foxa2-Wnt1 cko mutant embryos between E8.5 and E10.5. Importantly, both genes are also required to inhibit the expression of Gli2 in progenitors. A model showing the regulatory interactions among these genes revealed from our study are summarised in Fig. 9 .
Our results also demonstrate that Foxa1 and Shh expression in ventral midbrain progenitors are lost at E8.5 but recovers by E10.5 in Foxa2-Wnt1 cko mutant embryos. These results suggest that the expression of Foxa1 and Shh becomes independent of Foxa2 in midbrain basal progenitors at later stages. Which molecule is responsible for the recovery of Foxa1 and Shh in basal plate progenitors of Foxa2-Wnt1 cko mutant embryos? The cyclopamine treatment experiments suggest that Shh signalling is not required for the recovery of Foxa1 expression. Further experiments will be required to identify the nature of the molecule responsible for the recovery of Foxa1 expression in these mutant embryos.
3.2.
Foxa1 and Foxa2 acts upstream and downstream of Shh signalling to regulate midbrain progenitor identity Foxa1 and Foxa2 are required upstream of Shh for inducing its expression in basal plate progenitors in the midbrain. Each ChIP was performed on chromatin samples from three biological replicates, and enrichment of all Gli2 elements in the ChIP samples compared with input chromatin was statistically significant (P < 0.05). In addition, our data indicate additional roles for Foxa1 and Foxa2 in regulating the patterning of progenitors by inhibiting the expression of Nkx2.2 in ventral midbrain progenitors. How does Foxa1/2 regulate the expression of Nkx2.2 in the midbrain? ChIP experiments with E12.5 midbrain dopaminergic cells provided evidence that Foxa2 directly binds to upstream promoter regulatory sequences of Nkx2.2 (Lin et al., 2009) . Hence, our earlier study suggests that Foxa2 directly inhibit Nkx2.2. expression. In addition, data from this paper indicate that Foxa1/2 also regulate the ventral limit of Ptch1, Gli1 and Gli2 expression in the midbrain. Consequently, there is a prolonged period of expression of all three genes in ventral midbrain progenitors lacking Foxa2 in Foxa2; Wnt1 cko mutant embryos. Continued expression of direct targets of Shh signalling, Ptch1 and Gli1 in these progenitors from E9.5 to E10.5, indicate that the duration of Shh signalling is increased in these ventral midbrain progenitors of Foxa2; Wnt1 cko mutants. Since Nkx2.2 expression is still dependent on Shh signalling at E9.5 based on the embryo culture experiments with cyclopamine treatment, the increased duration of Shh signalling likely also contributes to the expansion of Nkx2.2 expression in the ventral midbrain of Foxa2-Wnt1 cko mutant embryos from E9.5 to E12.5. We therefore propose that inhibition of Nkx2.2 expression in midbrain basal progenitors from E9.5 onwards is a consequence of Foxa1/2 modulating Shh signalling via regulation of expression of its intracellular transducers, Gli1 and Gli2 and also by a direct regulation of Nkx2.2 (Lin et al., 2009 ). Foxa1/2 therefore play multiple roles in orchestrating a cell's response to Shh signalling. Our new findings suggest that Foxa1/2 act downstream of Shh to alter a cell's competence to respond to Shh signalling, by directly repressing Gli2 expression, and is consistent with recent published data from embryological experiments in chick and mouse .
Foxa1 and Foxa2 have similar roles in regulating the development of ventral midbrain neurons
Loss of Foxa1 and Foxa2 alone leads only to transient loss while loss of both genes lead to a permanent loss of ventral midbrain neurons. These genetic data indicate that Foxa1 and Foxa2 can compensate for each other's function in the development of OCM, red nucleus and DA ventral midbrain neurons. In agreement, the recovery of Nkx2.2, Gli1 and Gli2 expression correlates with the activation of Foxa1 expression in basal plate midbrain progenitors of Wnt1cre; Foxa2 cko embryos. We also show that Foxa1 and Foxa2 are both able to induce Shh expression in over-expression studies. Hence, our study did not reveal any differences in the activities of Foxa1 and Foxa2. Our results, however, highlight a difference in the timing of their activation. The distinct regulation of Foxa1 and Foxa2 expressions suggests that these two genes may have undergone selective evolution of enhancer regulatory sequences to facilitate their unique functions in the CNS. Generation of Foxa2
KIFoxa1 and Foxa1 KIFoxa2 mice will be necessary to determine if these genes have identical or overlapping functions during development and in adult mice. The identification of direct targets of Foxa1 and Foxa2 in the CNS by the ChIP-Seq method will also help to resolve this issue. These genes also negatively regulate both Gli2 (Fig. 6) , and Nkx2.2 expression (Lin et al., 2009) . Previous studies have shown that Gli2 regulate Gli1 expression in the midbrain (Matise et al., 1998) . In addition, Foxa2 also activates Foxa1 expression in basal progenitors (Fig. 3 ) and autoregulates its own expression (Sasaki and Hogan, 1996) . Shh expression is regulated by Gli and Foxa2 in the floor plate and by Shh in the notochord (Epstein et al., 1999) .
Materials and methods
Generation and genotyping of mutant embryos and animals
et al., 1998) with animals homozygous for the Foxa2 flox allele (Hallonet et al., 2002 were detected by PCR (Hallonet et al., 2003; Kaestner et al., 1999) , whereas the Cre transgene was detected by using a pair of primers and PCR conditions as described by Indra et al. (1999) . Shh flox/flox (Lewis et al., 2001) 
In situ hybridization (ISH), and immunohistochemistry of brain sections
Embryos or dissected brains were fixed for overnight at 4°C in 4% paraformaldehyde in 0.1 M PBS, cryoprotected with 30% sucrose in PBS, embedded in OCT compound (VWR International, Poole, UK), and cryosectioned on a cryostat (CM3050S; (Leica, Nussloch, Germany). Section in situ hybridization was performed as described previously (Myat et al., 1996) . The following mouse antisense RNA probe has been used: Gli1, Gli2, Gli3 (Hui et al., 1994) and Ptch1 (Puelles et al., 2004) . A minimum of three control and three mutant embryos were analyzed.
For immunohistochemistry, sections were incubated overnight at 4°C with the appropriate primary antibody diluted in 1% BSA in PBS. Sections were then extensively washed in PBS plus 0.1% BSA and incubated 1 h at room temperature with a secondary antibody conjugated with a fluorochrome (Molecular Probes). Sections were then washed and mounted in Vectashield H-1000 (Vector Laboratories, Burlingame, CA). The following primary antibodies were used: rabbit anti-Foxa2 (1:1000) (Filosa et al., 1997) , goat anti-Foxa2 (1:100) (sc-6554, Santa Cruz), guinea-pig anti-Foxa1 (1:500) (Wan et al., 2005) , mouse anti-Nkx2.2 (1:5) (74.5A5 Developmental Studies Hybridoma Bank), rabbit anti-TH (1:200) (AB152, Chemicon), rabbit anti-Shh (1:100) (sc-9024, Santa Cruz), mouse anti Brn3a (1:100) (sc-8429, Santa Cruz), and mouse anti Islet1 (1:20) (40.2D6, Developmental Studies Hybridoma Bank). In some cases, staining of nuclei with Toto-3 iodide (1:1000, Molecular Probes) was performed. All images were collected on a Leica TCS SP2 confocal microscope and processed with Adobe Photoshop 7.0 software (Adobe Systems, San Jose, CA).
Electroporation and culture of mouse embryos
Mouse embryos were obtained from pregnant F1 strain mice (CBA/Ca X C57BL/10) at 10.5 days postcoitum (E10.5) and were electroporated and cultured for two days according to Lin et al., 2009 . The pCIG vector was kindly provided Dr. A.P. McMahon. pCaggs-Foxa2 and pCaaggs-Foxa1 were made by cloning full length Foxa2 cDNA and Foxa1cDNA, respectively, into the pCaggs vector.
Mouse whole embryo culture was performed as previously described (Lin et al., 2009) . 20 mmol/L cyclopamine (TRC, Toronto, Canada) dissolved in ethanol were stored at À20°C as a stock solution. Two microlitre cyclopamine stock was added to the 2 mL medium in each culture vial, yielding 20 lmol/L of cyclopamine. Embryos were cultured from E9.5 for a period of 2 days.
ChIP
Foxa2-ChIP and mock-ChIP experiments were performed on dissected E12.5 ventral midbrain tissue as described (Lin et al., 2009 ), using Foxa2-specific antiserum (kind gift of J.A. Whitsett) and normal rabbit anti-IgG antibody (Millipore #12-370), respectively. The ChIP PCR primers spanned the Foxa2-binding sites within E1-5 region of mouse Gli2 genomic sequence. Primers spanning the Foxa2 binding sites in the Shh brain enhancer region (Epstein et al., 1999) were used as a positive control. A region upstream of the Gli2 gene together with the Foxa2 open reading frame were used as negative control regions for non-specific enrichment. E1, F-CTGAGTTTTTGCCCTCATCC: R-TCCCTACGCAAACATCAGTG: E2, F-TGTAAGGCTCCTGGCATCTC; R-GGGTCTTCTCTTTGG GAAGC; E3, F-AAGTTTTCCGGGAGTGGAAT; R-GGATTAGT-GAATCCG GGACA; E4, F-TGTGTGTGTGTGCAGGTTTG; R-GGGGAGGGATGAATCACTTT; E5, F-ACTCTCTGTGCGCTGTTC CT; R-TGGAGGGAGATGTGGAGTCT; Shh, F-GGAGAGGGGGT TGGAAGTATC; R-GTGAAAGCCCGAGACTTGTGT; GLI Àve, F-C CCCCTGGATGCTTTTCTG; R-TCAGGAATGGCATGCTGTCTT; Foxa2ORF, F-AGCAGAGCCCCAACAAGATG; R-TCTGCCGGTAG AAAGGGAAGA.
4.5.
ChIP-Seq
The sample was generated from Nestin-Enhancer-Lmx1a-stably transfected ES cells that have been differentiated into mDA progenitors as described in Andersson et al., 2006 . Cells were cross-linked as described previously (Lin et al., 2009) . After washing in PBS to remove excess formaldehyde and glycine, 2 · 10 7 fixed cells were homogenized in 300 lL of cold whole-cell lysis buffer (10 mM Tris-HCl at pH 8.0, 10 mM NaCl, 3 mM MgCl2, 1% NP-40, 1% SDS) and protease inhibitors. After incubating on ice for 10 min, lysates were sonicated using a Diagenode Bioruptor (30-s on/off pulses for 10 min, on high setting). Debris was removed by centrifugation at 13,000g for 10 min, and the supernatant was collected and snap frozen in liquid nitrogen. As input, 10 lL of sonicated chromatin was incubated in PBS with 200 mM NaCl overnight at 65°C, treated with proteinase K and purified with the QIAquick PCR Purification Kit (Qiagen). Immunoprecipitations were performed as previously described (Lin et al., 2009 ). For ChIP-Seq experiments, the immunoprecipitated DNA was modified for sequencing following the manufacturer's protocol (Illumina). Cluster generation and sequence alignment to the mouse genome (mm9) following pipeline processing were performed following Illumina's protocol. Only sequence tags uniquely mapping to the Gli2 locus were considered for this analysis. Immunoprecipitated DNA was also used to confirm enrichment of target DNA fragments via qPCR. PCR reactions were assembled in triplicate with Platinum SYBR Green Super mix (Invitrogen) and run using ABI 7900 PCR System (with dissociation curve). The enrichment of target sequences in ChIP material was calculated relative to the input.
Binding site search
Foxa2 binding sites were identified using the Jaspar database (http://jaspar.cgb.ki.se/). Conservation of the binding sites was assessed using CLUSTULW (http://clustalw.genome. ad.jp/), where sequences containing the putative Foxa2 binding sites in mouse were compared to those corresponding in Rat and Human.
